OnKure Therapeutics OKUR Balance Sheet (2020-2026)

NASDAQ OKUR
$3.27 -0.11 (-3.27%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

OnKure Therapeutics Quarterly Balance Sheet

Periods 26 quarters
Latest Jun 2026

OnKure Therapeutics reported total assets of $179.35M and total liabilities of $7.25M for the quarter ended Jun 2026, up 108.4% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
126.41M124.66M121.09M118.26M62.13M19.93M30.39M9.08M11.74M29.90M20.38M35.97M76.70M110.80M96.70M83.40M70.33M59.10M192.11M166.50M
Short-term InvestmentsInvestments (Current)
31.32M23.01M17.57M8.59M53.95M81.25M63.39M133.60M113.88M75.33M62.46M40.70M15.98M9.88M
Cash & Current Investments
157.73M147.67M138.66M126.85M116.08M101.17M93.79M142.68M125.61M105.23M82.83M76.67M92.68M110.80M96.70M83.40M70.33M59.10M192.11M176.39M
Securities - Tradable
9.88M
Prepaid Assets
4.93M6.06M4.05M5.16M4.92M5.18M3.23M3.64M3.16M3.89M1.09M1.32M0.33M2.24M1.51M1.18M1.20M1.79M5.38M1.29M
Current Assets
162.66M153.73M142.72M132.01M121.00M106.35M97.02M146.32M128.77M33.77M83.93M77.99M77.00M113.00M98.17M84.55M71.53M60.84M197.48M177.68M
Non-Current Assets
Property, Plant & Equipment (Net)
0.20M0.21M0.24M0.24M0.24M0.45M0.58M0.55M0.53M1.43M0.10M0.08M0.06M1.02M0.93M0.82M0.72M0.62M0.52M0.43M
Other Non-Current Assets
0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.06M0.06M0.15M0.15M0.11M0.11M0.12M0.10M0.27M0.41M0.40M
Non-Current Assets
0.28M0.29M1.70M1.60M1.51M1.83M1.85M1.72M1.62M1.97M0.71M0.73M0.65M1.90M1.71M1.52M1.31M1.28M1.21M1.68M
Assets
162.94M154.02M144.41M133.61M122.50M108.18M98.87M148.04M130.39M35.73M84.64M78.72M77.64M114.91M99.88M86.07M72.83M62.12M198.69M179.35M
Liabilities
Current Liabilities
Accounts Payables
1.27M2.02M1.57M1.56M2.19M1.89M1.80M1.83M2.47M3.42M0.68M0.06M0.24M2.97M2.34M2.38M1.29M1.43M11.02M2.00M
Payables
1.27M2.02M1.57M1.56M2.19M1.89M1.80M1.83M2.47M3.42M0.68M0.06M0.24M2.97M2.34M2.38M1.29M1.43M11.02M2.00M
Accumulated Expenses
5.08M4.18M5.89M6.37M6.85M4.83M8.32M11.59M10.77M3.66M1.81M0.95M0.72M7.03M5.89M4.66M4.39M3.94M2.90M4.31M
Other Accumulated Expenses
0.69M0.37M0.47M1.05M0.86M1.22M0.32M0.39M0.36M
Current Leases
0.46M0.41M0.41M0.40M0.36M0.32M0.33M0.21M0.33M0.33M0.29M0.54M0.55M0.56M0.57M0.55M0.41M0.34M
Total Current Liabilities
6.35M6.20M7.91M8.34M9.45M7.12M10.48M13.74M13.56M7.29M2.81M1.35M3.25M10.53M8.79M7.60M6.25M5.92M14.33M6.64M
Non-Current Liabilities
Non-Current Deffered Revenue
0.28M0.44M0.06M0.06M0.07M0.03M0.32M0.88M1.07M0.01M0.01M0.01M
Preferred Stock Liabilities
129.82M
Operating Leases
1.13M1.06M0.94M1.06M0.98M0.90M0.81M0.47M0.58M0.49M0.38M0.55M0.41M0.27M0.12M0.59M
Other Non-Current Liabilities
0.17M0.04M0.04M0.04M0.01M0.01M0.01M
Total Non-Current Liabilities
6.65M9.19M7.86M6.37M5.92M14.33M7.23M
Total Liabilities
6.74M6.81M9.09M9.45M10.46M8.21M11.78M15.51M15.44M7.75M3.40M1.85M3.63M11.08M9.23M7.90M6.41M5.93M14.34M7.25M
Shareholder's Equity
Common Equity
156.21M147.21M135.32M124.16M112.05M-54.42M87.08M132.53M114.94M-101.84M-111.26M-123.58M-135.05M103.83M90.65M78.17M66.43M56.18M184.35M172.11M
Liabilities and Shareholders Equity
162.94M154.02M144.41M133.61M122.50M108.18M98.87M148.04M130.39M35.73M84.64M78.72M77.64M114.91M99.88M86.07M72.83M62.12M198.69M179.35M
Retained Earnings
230.31M231.90M233.01M234.06M235.15M236.69M238.86M303.88M305.48M-102.05M308.15M309.14M309.97M258.55M261.30M264.20M267.17M270.42M413.75M416.86M
Preferred Shares
53.80M
Treasury Shares